Submit your email to push it up the queue
MediSense, Inc., a leading name in the healthcare technology sector, is headquartered in the United States and operates extensively across North America and Europe. Founded in 2005, the company has established itself as a pioneer in developing innovative medical devices and software solutions that enhance patient care and streamline clinical workflows. MediSense's core offerings include advanced diagnostic tools and integrated health management systems, distinguished by their user-friendly interfaces and robust data analytics capabilities. The company has achieved significant milestones, including multiple industry awards for its commitment to quality and innovation. With a strong market position, MediSense continues to drive advancements in healthcare technology, making a meaningful impact on patient outcomes and operational efficiency in medical facilities worldwide.
How does MediSense, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
MediSense, Inc.'s score of 59 is higher than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
MediSense, Inc., headquartered in the US, currently does not have specific carbon emissions data available for reporting. However, the company is part of a corporate family that includes Abbott Laboratories, from which it inherits emissions data and climate commitments. As a merged entity, MediSense, Inc. aligns its climate initiatives with those of Abbott Laboratories, which has established science-based targets (SBTi) for emissions reductions. While specific reduction targets for MediSense, Inc. are not detailed, the overarching commitments from Abbott Laboratories indicate a strong focus on sustainability and climate action. MediSense, Inc. is committed to addressing climate change through initiatives cascaded from Abbott Laboratories, which actively participates in the Carbon Disclosure Project (CDP) and has made significant pledges towards reducing its carbon footprint. The company is expected to follow similar pathways in its climate strategy, although specific metrics and targets for MediSense, Inc. have not been disclosed. In summary, while MediSense, Inc. does not currently report its own emissions data, it is positioned within a framework of robust climate commitments inherited from Abbott Laboratories, reflecting a dedication to sustainability and responsible environmental stewardship.
Access structured emissions data, company-specific emission factors, and source documents
2010 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Scope 1 | 578,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Scope 2 | 691,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Scope 3 | - | - | - | - | - | - | - | - | - | - | - | 00,000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
MediSense, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.